Drug trial aims to ease patients off Life-Support machines
NCT ID NCT04158674
Summary
This study tested whether a drug called levosimendan could help patients with severe, sudden heart failure safely stop using a temporary heart-lung machine (ECLS). The drug is designed to strengthen the heart's pumping ability. Researchers compared the drug to a placebo in 82 hospitalized adults to see if it reduced the chance of failing to come off the machine support.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE DECOMPENSATED HEART FAILURE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU Dijon Bourgogne
Dijon, 21079, France
Conditions
Explore the condition pages connected to this study.